Back

Echocardiographic effects of an angiotensin receptor-neprilysin inhibitor after transcatheter aortic valve implantation: a substudy of a randomized trial

31 August 2026 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Echocardiographic phenotypes in contemporary valve disease Valvular Heart Disease ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Shogo Okita

Chiba University, Chiba (Japan)

7 More presentations in this session

Presentation thumbnail
Prognostic value of mean gradient to aortic valve area ratio (MG:AVA) in paradoxical low-flow low-gradient aortic stenosis (LFLGAS)
Associate Professor W. Wang (Brisbane, AU)
Abstract Slides Video
Presentation thumbnail
Validation of a multi-video view-informed vision-language model for valvular heart disease assessment in japanese patients
Doctor H. Hayama (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Decreased carotid artery flow and increased resistive index as potential causes of aortic sclerosis-related cognitive dysfunction
Professor E. Choi (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Cardiac damage staging in rheumatic mitral stenosis
Doctor E. Lim (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
Myocardial work assessment in low-flow low-gradient aortic stenosis
Doctor J. Gopal (New Orleans, US)
Abstract Slides Video

Access the full session

Session thumbnail
Echocardiographic phenotypes in contemporary valve disease

The Event

Event poster

ESC Congress 2026

31 August 2026 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Sacubitril-valsartan and its effect on echocardiographic parameters
29 June 2021
thumbnail
Congress Presentation
Aortic stenosis and the evolution of cardiac damage after transcatheter aortic valve replacement.
30 August 2024
thumbnail
Congress Presentation
Myocardial work as an independent predictor of postoperative NT-proBNP after transcatether aortic valve replacement
11 May 2023
thumbnail
Congress Presentation
Prognostic value of LVEF in patients undergoing TAVI: a meta-analysis of 75,085 patients
13 December 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources